Portfolio – Apr 07, 2025 HighLife granted US FDA Breakthrough Device Designation for its TMVR solution Read More
Portfolio – Mar 20, 2025 Next-generation Revenue Intelligence Software Buynomics Secures $30M Million in Series B Funding to Expand AI-driven Commercial Operating System Read More
Firm – Mar 18, 2025 SaaS veteran and long-time Nexthink C-level executive Yassine Zaied joins Swiss VC Vi Partners as Operating Partner to accelerate scaleups Read More
Portfolio – Mar 17, 2025 Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech Read More
Portfolio – Feb 27, 2025 Unique Secures USD $30 Million Series A to Pioneer Agentic AI Workforce in Financial Services Read More
Portfolio – Feb 14, 2025 Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares Read More
Portfolio – Jan 27, 2025 AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa for an ultra-rare autoimmune disease Read More
Portfolio – Jan 08, 2025 Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris' AraLinQTM technology Read More
Portfolio – Jan 07, 2025 Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval Read More
Portfolio – Jan 07, 2025 Vara's AI-Supported Mammography Revolutionizes Breast Cancer Detection: Landmark German Study Confirms Real-World Impact Read More
Portfolio – Jan 06, 2025 Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy Read More
Portfolio – Dec 19, 2024 MedLumics Announces the Completion of the FIM Study, With Successful Remapping at 3 Months, Demonstrating the Efficacy of the AblaView® Optically Guided Pulsed Field Ablation (PFA) System and Presentation at the AF Symposium 2025 Read More
Portfolio – Nov 26, 2024 Oplit welcomes Vi Partners as a new investor to accelerate its European expansion and strengthen R&D investments Read More
Portfolio – Nov 14, 2024 RealWear acquires smartglasses innovator Almer to supercharge the industrial adoption of wearables, backed by TeamViewer Read More
Portfolio – Nov 09, 2024 MedLumics' Groundbreaking Trial Demonstrates a Quantum Leap for Optical Guidance in Atrial Fibrillation Treatment Read More
Portfolio – Nov 08, 2024 Vara raises $8.9 million to expand AI-enabled early breast cancer detection to India Read More
Portfolio – Oct 25, 2024 Vara's Groundbreaking Research Demonstrates Potential of AI to Transform Breast Cancer Detection Worldwide Read More
Portfolio – Oct 08, 2024 Somagenetix AG secures CHF 10 million in Series A to advance lentiviral gene therapy for Chronic Granulomatous Disease Read More
Portfolio – Sep 18, 2024 Almer Technologies secures 3 million USD in new funding round, led by Vi Partners Read More
Portfolio – Aug 22, 2024 FLOWIT AG Successfully Closes Oversubscribed First Funding Round: 4 MM CHF Read More
Portfolio – Jul 25, 2024 Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix Read More
)
)
)
){kind=logo}
)
){kind=logo}
)
)
)
)
){kind=logo}
)
)
)
){kind=logo}
)
)
)
)
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
)
)
)
)
)
)